SO
CRVS icon

STRS Ohio’s Corvus Pharmaceuticals CRVS Stock Holding History

STRS Ohio’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,100
Closed -$12K – 2128
2018
Q1 		$12K Hold
1,100
– – ﹤0.01% 1835
2017
Q4 		$11K Hold
1,100
– – ﹤0.01% 1844
2017
Q3 		$17K Hold
1,100
– – ﹤0.01% 1874
2017
Q2 		$13K Hold
1,100
– – ﹤0.01% 1892
2017
Q1 		$22K Hold
1,100
– – ﹤0.01% 1827
2016
Q4 		$15K Hold
1,100
– – ﹤0.01% 1868
2016
Q3 		$18K Hold
1,100
– – ﹤0.01% 1847
2016
Q2 		$15K Buy
+1,100
New +$14.9K ﹤0.01% 1873

Other funds holding CRVS

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return